AGENDA

The Imaging in 20/20 meeting for September 15-19, 2024 is a celebration of developments over the past 22 years, when the meeting series was initiated. Speakers include faculty who have had a significant impact on both conventional and molecular imaging over the years. Topics cover a wide range of imaging modalities and biomedical applications. An emphasis is placed on provocative research topics that can spur collegial debates and discussions which promote interactions and networking, ultimately accelerating imaging research studies into the future.

Download Agenda

Sunday, September 15

16:00 – 18:00: Registration & Welcome Reception (Trappers Room)
18:00 – 19:00: Dinner (Wranglers Room)
19:00 – 19:15: Welcome (Explorers Room)
19:15 – 21:30: SESSION 1: THERANOSTIC CONCEPTS (Explorers Room)

  • Jason Lewis: Theranostics: Challenges and opportunities
  • H. Charles Manning: MD Anderson RADIATE: a model for academic theranostics discovery at industry scale

21:30 – 22:00: Reception & Poster Session (Trappers Room)

Monday, September 16
07:00 – 08:30: Breakfast Buffet (Mural Dining Room)
08:30 – 10:15: SESSION 1 CONTINUED & SESSION 2: THE CHEMISTRY OF THERANOSTICS (Explorers Room)

  • Steven Rowe: PSMA-targeted imaging and therapy in prostate cancer
  • Carolyn J. Anderson: The building blocks of theranostics: targeting molecules, linkers, chelators, and radionuclides

10:15 – 10:30: Morning Break (Trappers Room)
10:30 – 12:00: SESSION 2 CONTINUED (Explorers Room)

  • Andrew Horti: New 18F-radiotracers with covalent C-F bond for FAP imaging
  • Sangeeta Ray: Theranostics for prostate cancer and beyond

12:00 – 13:00: Lunch (Wranglers Room)
13:00 – 17:00: Afternoon Free Time & Optional Activities
17:00 – 18:00: Reception & Poster Session (Trappers Room)
18:00 – 19:00: Dinner (Wranglers Room)
19:00 – 21:15: SESSION 3: THERANOSTICS IN PRECISION MEDICINE (Explorers Room)

  • Phuoc Tran: The promise of theranostics for oligometastatic prostate cancer: Going beneath the surface with molecular imaging & radiotherapy
  • Lilja Solnes: Theranostics in clinical practice: Bridging research & patient care
  • Philippe Bishop: Preferential tumor-to-normal tissue biodistribution with ABD147 DLL3-targeted radioligand

21:15 – 22:00: Reception & Poster Session (Trappers Room)

Tuesday, September 17

07:00 – 08:30: Breakfast Buffet (Mural Dining Room)
08:30 – 10:00: SESSION 4: AI IN MOLECULAR IMAGING & THERAPY (Explorers Room)

  • Baris Turkbey: Translational AI in Prostate Cancer Management
  • Maryellen Giger: Role of MIDRC in molecular imaging and theranostics

10:00 – 10:30: Morning Break & Group Photo (Trappers Room & Patio)
10:30 – 12:00: SESSION 4 CONTINUED (Explorers Room)

  • Abhinav Jha: What can AI do for you: An AI developer’s take on strengthening clinical nuclear medicine with deep learning
  • Zahi Fayad: Heart health digital twins: Predictive models for personalized care, precision prevention, and healthspan extension

12:00 – 13:00: Lunch (Wranglers Room)
13:00 – 17:00: Afternoon Free Time & Optional Activities
17:00, 17:30: Bus to Diamond Cross Ranch (Bus Parking Lot)
17:15 – 21:45: KEYNOTE RECEPTION & DINNER (Diamond Cross Ranch)

  • Robert Flavell: CD46 targeted theranostics for imaging and treatment of prostate cancer

21:15, 21:45: Bus to Jackson Lake Lodge

Wednesday, September 18

07:00 – 08:30: Breakfast Buffet (Mural Dining Room) 08:30 – 10:00: SESSION 6: INNOVATIONS I (Explorers Room)

  • Neil Bander: Therapeutics: Ligands or antibodies
  • Jan Grimm: Cerenkov imaging in theranostics

10:00 – 10:15: Morning Break (Trappers Room)
10:15 – 11:45: SESSION 6 CONTINUED (Explorers Room)

  • Michael Michaelides: Translational tools for mapping and modulating the brain
  • Mekhail Anwar: Wearable SPECT using the chip-scale SENTRI platform for personalized theranostics

11:45 – 12:30: Lunch (Wranglers Room)
12:30 – 17:00: Afternoon Free Time & Optional Activities
17:00 – 18:00: Reception & Poster Session (Trappers Room)
18:00 – 19:15: Dinner (Wranglers Room)
19:15 – 20:45: SESSION 7: DRUG DEVELOPMENT (Explorers Room)

  • Zhengong Lee: PSMA beyond prostate cancer – theranostic implications
  • Brian Shuch: Seeing CLEARly with Molecular Imaging in RCC: The emergence of 89Zr-girentuximab

20:45 – 22:00: Reception & Poster Session (Trappers Room)

Thursday, September 19

07:00 – 08:30: Breakfast Buffet (Mural Dining Room)
08:30 – 10:45: SESSION 8: INNOVATIONS II (Explorers Room)

  • Sunil Singhal: Intraoperative molecular imaging of lung cancer
  • Nerissa Viola: The re-emergence of antibody-based radiotheranostics: Guess it’s back? Back again.
  • Michael Evans: Chemical strategies to expand the therapeutic window for targeted radiotherapies

10:45 – 11:00: Wrap-Up and Good-bye (Explorers Room)